GE Healthcare and Novavax have a vision - a state-of-the-art
pandemic influenza vaccine manufacturing facility solution with the
ability to produce vaccines quickly, which can be marketed as a
product to international countries.
Microscopy expert-Carl Zeiss has licensed a new fluorescence
microscopy technique that enables scientists to determine the
precise intracellular location of proteins of interest.
Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI
Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and
strengthen its oncology pipeline.
GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos
in a new development partnership, in a deal worth up to €218m for
the Belgian biotech.
Separations expert Millipore is collaborating with Rohm and Haas
Company to develop new high-performance chromatography products for
use in biopharmaceutical manufacturing.
UK-based William Ransom & Son has been advised to voluntarily
recall certain products following a false contamination scare at
its Witham, Essex, facility.
A new genetic identity test that can be used to confirm the breed
and origin of meat from farm animals has been developed to enable
complete meat traceability.
Eisai is planning to step up its clinical research presence in Asia
and has chosen Singapore as a hub from which to coordinate its
research activities.
Bristol-Myers Squibb (BMS) has finally detailed its plans to trim
the fat and save cash, months after first revealing that big
changes would be on the cards.
LabTechnologist.com brings you a periodic round up of new product
releases from Carl Zeiss SMT, Genetix, Ludesi, Millipore, Nikon,
Olympus and Wiley-VCH.
Abbott is to shut its doors on its Galway, Ireland, facility -
taking 500 jobs with it - as the market moves into murky waters
over the future of vascular stents.
UK researchers have published results that show that microfluidic
devices can provide robust quantitative pharmacological information
from low numbers of single cells.
Sanofi-Aventis has opened its first Asian research and development
centre in Goa, India, signalling its ambition to further tap in to
this region's budding pharma scene.
Pharmaceutical Profiles, H.D. Smith, Consort Medical, Questcor
Pharmaceuticals, and Sunesis Pharmaceuticals have all had people on
the move in the world of pharmaceutical manufacturing.
As eClinical gathers momentum, Outsourcing-Pharma.com spoke to two
contract research organisations (CROs), Icon and Parexel, to get
their views on the present and future of these emerging
technologies.
Canadian researchers have devised a method of extracting the
complete proton NMR (nuclear magnetic resonance) spectra for a
component of a mixture without the need for physical separation.
Morphosys has landed in the money after scoring a lucrative 10 year
antibody development deal with Novartis and as a result, will now
place all its eggs in one basket and cut ties with its
fee-for-service customers.
Gene expression analysis expert Exiqon is to pay up to $45m
(€30.7m) for diagnostics company Oncotech as a first step towards
becoming a world leading miRNA diagnostic manufacturer.
Medgenics' Biopump could be the solution to the issues surrounding
protein therapy and is set to take on the $51bn US
biopharmaceutical market after raising £3.28m ($6.76m) in funding
in its Initial Public Offering.
Bruker BioSciences is to acquire the affiliated, but privately-held
Bruker BioSpin group for $914m (€620m) in a bid to expand its
distribution capabilities and increase its customer base.
Spanish firm Almirall is working on a new chronic obstructive
pulmonary disease (COPD) treatment combined with a hi-tech easy use
inhaler, creating what it hopes will be another competitive product
from its in-house pipeline.
Pfizer is looking to Asia for both R&D and manufacturing
outsourcing and to help it cut costs in a bid to mitigate the
effects of patent expiries and competition from generic drugs.
Sanofi-Aventis recently admitted it needed to increase the number
of biotech compounds in its pipeline and now, true to its word, the
French pharma heavyweight has signed a big antibody deal with US
biotech Regeneron.
The World Economic Forum has announced this year's 'Technology
Pioneers', firms which have developed a life-changing technology
innovation that has the potential for long-term impact on both
business and society.
Veeco's patent infringement case against Asylum Research is set to
go to court after a US Court ruled that three of Veeco's atomic
force microscopy (AFM) patents were potentially being breached.
Merck has settled on a site in south east Ireland for a new
vaccines and biologics facility, investing €200m ($280m) in its
third facility on the island.
Specialty pharmaceutical company Akorn has signed up with
India-based Cipla in an exclusive manufacturing and supply
agreement for an undisclosed inhaled drug.
Japanese drugmaker Astellas has agreed to acquire US biotech firm
Agensys as part of its plan to ramp up antibody research,
especially in the field of cancer.
Researchers have developed a nanoparticle signalling system that
can be used as cellular 'nano-flares' that enable the visualisation
and quantification of RNA in living cells.
GVK Bio has reinforced its claim to be India's top contract
research organisation with a 100-crore ($25m) push from a private
investment company. The funds will be used to expand its drug
discovery services and push further into...
The UK has become an unlikely hub for drug counterfeiters, with the
UK Medicines and Healthcare products Regulatory Agency (MHRA) last
week launching its new three-year action plan to tackle the recent
surge in drug fakes head on.
The official report into good manufacturing practice (GMP) failures
that caused dangerous contamination and a Europe-wide recall of
Roche's HIV drug Viracept (nelfinavir) claims the firm simply did
not understand its own manufacturing...
The quest for more efficient methods of generating biofuels has
been boosted by a metagenomic study of the gut bacteria that enable
termites to digest wood.
